AgingResearch.News
Nature Medicine

Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial

By Pablo García-Pavía, Francesco Cappelli, Margot K. Davis, Show 20 more authorsMathew S. Maurer
Trial in peopleInterventions
Paper

The paper

Pablo García-Pavía, Francesco Cappelli, Margot K. Davis, Show 20 more authorsMathew S. Maurer

Spanish National Centre for Cardiovascular Research; Columbia University Irving Medical Center

Nature Medicine, 30 Aug 2026

doi.org/10.1038/s41591-026-04670-6PubMed 42742182

More in Interventions